Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate for painless gastrointestinal endoscopy in elderly patients
ChiCTR2100054129Phase 4Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in gastrointestinal conditions (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Sedation success rate. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2100054129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054129.